What makes AHS feel like home? Hear from our members about the mentorship, collaboration, and lifelong connections they’ve found while advancing #HeadacheMedicine together.
Join AHS or renew your membership today: https://t.co/Jy1ZO7HLfc
Last call: #HeadacheAcademy applications close Sunday, Oct 25! Open to PGY-3+ residents, headache fellows & MD/PhD clinicians/researchers in training or within 5 yrs of completion, located in the US, Canada, or Latin America. Apply here: https://t.co/kaNVk5dAhQ
Friday, Dec 4 is AHS Day at #AHSAZ! Wear your AHS gear to show your AHS pride. Order your swag now so it arrives in time to pack for Scottsdale. Tag us in your photos using #AHSAZ
View ShopAHS here: https://t.co/QqvhGnz55J
The AHS LGBTQIA+ Health Special Interest Group advocates for patients and providers who identify as LGBTQIA+, as sexual and gender minorities have a higher incidence of #headachedisorders compared to the general population. Learn more from Dr. Barber here: https://t.co/g9aqJvoLj6
Ready to elevate your headache care?
At #AHSAZ, the 2026 Scottsdale Headache Symposium, you can learn the latest in diagnosis and treatment from leading experts, earn CME, and connect with the AHS community.
Register by Oct. 29 to save: https://t.co/OnNDG3iQnB
Happy #NationalPrimaryCareWeek! Thank you to the Primary Care Practitioners who are often the first line of support for patients living with #migraine and #headache disorders.
Learn more about free #AHSFirstContact Resources here: https://t.co/mV6dd5ZssN
AHS 2027 membership renewals are open!
Not a member yet? Join today for access to CME, research, networking, and more. Be a part of the community advancing #headachemedicine.
Join or renew here to take advantage of all AHS has to offer: https://t.co/yqg5iWzeQu
Join us for the @miles4migraine Run/Walk/Relax on Sat, Dec 5 in conjunction with #AHSAZ! All are welcome to join and raise awareness for #migraine & #headache disorders. Learn more and register today: https://t.co/5VJJE9bsHS
Register for #AHSAZ here: https://t.co/zkdFzWQddQ
Applications now open for AHS’s 2027 Headache Academy! Learn from world-leading experts in migraine, cluster headache & primary headache disorders, plus training in clinical trial methods & research publication. Review the criteria and apply here: https://t.co/lQ4v79xrGT
Happy #AdvancedPracticeProvidersWeek! AHS celebrates NPs & PAs whose skill and compassion bring relief to patients with #headache and #migraine disease.
Learn more about how the AHS APP SIG supports the growing role of APPs in #headachemedicine https://t.co/mbL5HkYVZp
Open Access:
How early can function improve w #migraine prevention?
Across 3 phase 3 trials, #atogepant was associated w early improvements in daily functioning, w differences emerging w/in first 4 weeks.
@rashmihalker@JHCDrScott@DawnBuse
Read more: https://t.co/pSPJKJ3kUD
Upcoming Webinar: Join the AHS Women's Health SIG webinar: "Post-traumatic Headache in Women" Oct 2 at 7PM ET. Free to all AHS Members!
Learn more and register today: https://t.co/DD8NH239oC
#AHSSessionHighlight
Don’t miss “Pharmacology Clinical Conundrums” at this year’s #AHSAZ! This session will dig into real-world treatment challenges.
Learn more and register to join us today: https://t.co/hhm5T38fdF
AHS & @AANMember just published updated guidelines to help clinicians choose the most effective #migraine prevention treatments for adults, covering new & established options for chronic & episodic migraine. Learn more here: https://t.co/6Da16R8egS
@HeadacheJournal
Options for acute #migraine treatment when CV risk limits #triptan use?
A meta-analysis found #lasmiditan improved 2-h #pain freedom, with no vasoconstrictive CV events detected across 5,126 trial participants.
Read more: https://t.co/0xzg0SSUlJ
Mastering #Migraine Therapies is back!
MMT On Demand: expert lectures on acute treatment, prevention, diagnosis & more.
Next Live Q&A: Wed, Nov 4, 7 PM ET
Access & register here: https://t.co/b9FZi7daTd #MasteringMigraine
The 2026 AHS Investigator Initiated Grant Program is now accepting Letters of Intent. Advancing research that improves lives in #headachemedicine.
LOI Deadline: Sept 30, 2026
Learn more & submit here: https://t.co/BWD6GwvHDI
Our kickoff editorial is out, and the #Headache Innovation Challenge begins! For 16 weeks, we’ll spotlight unanswered questions from the 2024 AHS/NINDS Headache Research Priorities. Read & join us: https://t.co/onW08YyrIj #HeadacheResearchPriorities#InnovationChallenge